¶µ¼ø

¾å±à¡¡¾½°ì

¶µ¼ø¼Ì¿¿

ÌÚ»³¡¡½¨ºÈ
ÄÚÀî¡¡¹±µ×
ë¸ý¡¡Í³»Þ
ÁÒÅÄ¡¡ÆóϺ
¶áÆ£¡¡°ìϺ
»°Èø¡¡Ç«
ºù°æ¡¡¹¯ÎÉ
¼¯À¥¡¡ÍÛ°ì
¿Ü±Ê¡¡¹¨
Æ£°æ¡¡ÃÒ»Ò

½Ú¶µ¼ø

¾±»Ê¡¡Ï¹­
¹á¼è¡¡¿®Ç·
°ºÀî¡¡Í­¹á»Ò
ã·Æ£¡¡·ÉÂÀ
ÌÚÅÄ¡¡¹¯ÂÀϺ
»³Àî¡¡·òÂÀϺ

¹Ö»Õ

¾È°æ¡¡µ®»Ò
Æⳤ¡¡¸ù
±óÆ£¡¡¿·Âç
Ê¡Åç¡¡Åì¹À
ÃÓÅÄ¡¡¹ÀÊ¿
¥Ï¥·¥Á¥¦¥©¥ô¥£¥Ã¥Á¡¡¥È¥Þ¥·¥å
¾®ÃÓ¡¡Àµ²Å
µÜºê¡¡Íº²ð

¹ÖºÂ¡Ê¸¦µæ¼¼¡Ë¤Î³µÍ×
¡¡¾¼Ï£´£´Ç¯³«¹Ö¡£ÆüËܤǤϺǤâ¸Å¤¤Îò»Ë¤ò¤â¤ÄËã¿ì²Ê³Ø¹ÖºÂ¤Î¤Ê¤«¤Î°ì¤Ä¡£¸½ºß¤Ï¡¢Ëܱ¡¤Ë¤ª¤±¤ë£³¤Ä¤Î¿ÇÎÅÉô¡ÊËã¿ìÉô¡¢½¸Ãæ¼£ÎÅÉô¡¢¥Ú¥¤¥ó¥¯¥ê¥Ë¥Ã¥¯¡Ë¤ÈÉí°£³É±¡¤ÎËã¿ìÉô¤ò¡¢Ìó£±£°£°¿Í¤Î°å¶É°÷¤Ç¥«¥Ð¡¼¤·¤Æ¤¤¤Þ¤¹¡£¤³¤ÎÂç³Ø½ê°°å¶É°÷¿ô¤Ï¡¢ÆüËܤǤϺÇÂ絬ÌϤò¸Ø¤Ã¤Æ¤¤¤Þ¤¹¡£³¤³°¤Ø¤Îα³Ø¡ÊÎ×¾²¤È¸¦µæ¡Ë¤âÀѶËŪ¤Ë°¶Àû¤·¤Æ¤ª¤ê¡¢¸½ºß£²Ì¾¤Î°å¶É°÷¤¬³¤³°¤Ç¸¦ïÓ¤·¤Æ¤¤¤Þ¤¹¡£
°å³Ø²Ê¶µ°é¤Ë¤Ä¤¤¤Æ
¡¡3ǯÀ¸¤ËÂФ·¡¢Ëã¿ì¤ÎÁíÏÀŪ¤Ê¹ÖµÁ¡Ê·×2²ó¡Ë¤ò¹Ô¤Ã¤Æ¤¤¤Þ¤¹¡£4ǯÀ¸¤ËÂФ·¤Æ¤Ï½µ1²ó¤Î¼þ½Ñ´ü¼Â½¬¤ò¥°¥ë¡¼¥×¤Ëʬ¤±¤Æ4¥ö·î´Ö¼Â»Ü¡£¤µ¤é¤Ë¡¢4¡Á5ǯÀ¸Á´°÷¤ËÂФ·¤Æ1½µ´Ö¤ÎÎ×¾²¼Â½¬¤ò¡¢5¡Á6ǯÀ¸¤Î´õ˾¼Ô¤ËÂФ·¤Æ1¥ö·î¤ÎÁªÂò¼Â½¬¤ò¡¢¤½¤ì¤¾¤ì¹Ô¤Ã¤Æ¤¤¤Þ¤¹¡£
Âç³Ø±¡¶µ°é¡¦¸¦µæ¤Ë¤Ä¤¤¤Æ
¡¡Âç³Ø±¡¿Ê³Ø¼Ô¤Ï¡¢´ðËÜŪ¤Ë¼«Ê¬¤Î¸¦µæ¥Æ¡¼¥Þ¤Ë¤¢¤Ã¤¿´ðÁ÷Ϲֺ¤ËÇÛ°¤µ¤ì¤Þ¤¹¡£²áµî£³Ç¯´Ö¤ò¤ß¤ë¤È¡¢ºÙ˦À¸Íý³Ø¹ÖºÂ¡¢¿À·Ð²Ê³Ø¸¦µæÉô¤Ë¤Æ¸¦µæ¤ò¹Ô¤Ã¤Æ¤¤¤Þ¤¹¡£Âç³Ø±¡À¸¤Î¾ì¹ç¡¢Î×¾²¤Îduty¤Ï¤¢¤ê¤Þ¤»¤ó¡£
¹ÖºÂ(¸¦µæ¼¼)¤«¤é¤Î¥á¥Ã¥»¡¼¥¸
¡¡Ëã¿ì²Ê³Ø¹ÖºÂ¤Ë¤Ï¡¢physician-scientist¤òÌܻؤ¹Ëã¿ì²Ê°å¤ò°é¤Æ¤è¤¦¤È¤¹¤ë´Ä¶­¤¬¤¢¤ê¤Þ¤¹¡£Ì¤Íè¤ÎËã¿ì²Ê³Ø¤ò¥ê¡¼¥É¤·¤è¤¦¤È¤¤¤¦°ÕÍߤ¢¤ëÊý¤òµá¤á¤Æ¤¤¤Þ¤¹¡£
¢¥ ¤³¤Î¥Ú¡¼¥¸¤Î¥È¥Ã¥×¤Ø
¶µ°éôÅö
¹ÖµÁ²ÊÌÜ̾¾Î¤ÈÂоݳØǯ
Î×¾²°å³Ø­µ¡¦Ëã¿ìÁÉÀ¸¡¦áÖÄ˳ءʰå³Ø²Ê3ǯÀ¸¡Ë
´ðËÜŪÎ×¾²µ»Ç½¼Â½¬¡Ê¼þ½Ñ´ü¡Ë¡Ê°å³Ø²Ê4ǯÀ¸¡Ë
¼Â½¬²ÊÌÜ̾¾Î¤ÈÂоݳØǯ
Á´²ÊÎ×¾²¼Â½¬¡Ê°å³Ø²Ê£´¡¦£µÇ¯À¸¡Ë
¿ÇÎÅ»²²Ã·¿Î×¾²¼Â½¬¡Ê°å³Ø²Ê£µ¡¦£¶Ç¯À¸¡Ë
¢¥ ¤³¤Î¥Ú¡¼¥¸¤Î¥È¥Ã¥×¤Ø
Âç³Ø±¡Ã´Åö²ÊÌÜ̾¾Î
Âç³Ø±¡¥¬¥¤¥É¼ø¶ÈºÙÌÜ¡¡¡¡Ëã¿ì²Ê³Ø¡¦¿¯½±Ëɸæ°å³Ø¡Ê62¥Ú¡¼¥¸¡Ë¤ò¤´»²¾È¤¯¤À¤µ¤¤
¢¥ ¤³¤Î¥Ú¡¼¥¸¤Î¥È¥Ã¥×¤Ø
¼ç¤Ê¸¦µæ¥Æ¡¼¥Þ
¶µ°é¡¦¸¦µæ³µÍ×
  1. ËýÀ­áÖÄË´µ¼Ô¥ì¥¸¥¹¥È¥ê¤Î¹½ÃÛ¤ÈÅÐÏ¿¤Ë´Ø¤¹¤ë¸¦µæ
  2. Èó¿´Â¡¼ê½ÑÃæÄã·ì°µ¥¤¥Ù¥ó¥È¤Îȯ¸½¤È½Ñ¸åµÞÀ­¿Õ¾ã³²¤È¤Î´ØÏ¢À­¤Ë´Ø¤¹¤ë¼ÂÂÖÄ´ºº
  3. ·ÐƬ³¸¥«¥é¡¼¥É¥×¥é¡¼Ë¡¤òÍѤ¤¤¿¿·¤·¤¤Ç¾Þõή¬ÄêË¡¤Î³«È¯
  4. DPC¥Ç¡¼¥¿¥Ù¡¼¥¹¤òÍѤ¤¤¿Ëã¿ì¸å¤Î¹çÊ»¾É¤Ë´Ø¤¹¤ëÄ´ºº
  5. Bispectral Index®¤Ë±Æ¶Á¤òÍ¿¤¨¤ë°ø»Ò¤Ë´Ø¤¹¤ë¸¦µæ
  6. ¶ÚÃд˺îÍÑÙɹ³Ìô¥¹¥¬¥Þ¥Ç¥¯¥¹¤Î»êŬÅêÍ¿Î̤˴ؤ¹¤ë¸¡Æ¤
  7. ½ÑÁ°¿´ÅÅ¿Þ°Û¾ï¤Î½ÑÃ桦½Ñ¸å¿´·ì´É·Ï¥¤¥Ù¥ó¥ÈȯÀ¸Í½Â¬¤Ë¤ª¤±¤ëÍ­ÍÑÀ­¤Î¸¡Æ¤
  8. ½ÑÃæ¿´ÅÅ¿Þ¤ÎQT»þ´ÖÊѲ½¤Ë´Ø¤ï¤ë°ø»Ò¤ÎÄ´ºº
  9. ½ÑÁ°É¾²Á¤ËÍѤ¤¤ëASA-physical status¤Ï»à˴Ψ¤ª¤è¤Ó¹çÊ»¾ÉȯÀ¸Î¨¤òÈ¿±Ç¤·¤Æ¤¤¤ë¤«¡©
  10. µÛÆþËã¿ìÌô¤«¤é¤Î³ÐÀä˱ƶÁ¤òÍ¿¤¨¤ë°ø»Ò
  11. ½ÑÁ°BNPÃͤÈͽ¸å¤Î´Ø·¸¤Ë´Ø¤¹¤ëÄ´ºº
  12. ½ÑÃæ½Û´Ä°Ý»ýÊýË¡¤È¥¢¥¦¥È¥«¥à¤Î´Ø·¸¤Ë´Ø¤¹¤ë¸¦µæ
  13. ½ÑÁ°¿Õµ¡Ç½Äã²¼´µ¼Ô¤Ë¤ª¤±¤ë½Ñ¸å¿Õ¾ã³²°­²½Î¨¤Ë¤Ä¤¤¤Æ¤ÎÄ´ºº
  14. ½ÑÃæÄãÂβ¹¤òÍ褹°ø»Ò¤ÎÄ´ºº¤ª¤è¤ÓÄãÂβ¹¤¬½Ñ¸å¥¢¥¦¥È¥«¥à¤ËÍ¿¤¨¤ë±Æ¶Á¤Î¸¡Æ¤
  15. ½ÑÁ°¸ÆµÛµ¡Ç½¸¡ºº¤Î½ÑÃ桦½Ñ¸å¹çÊ»¾É¤ÎȯÀ¸Í½Â¬¤Ë¤ª¤±¤ëÍ­ÍÑÀ­¤Î¸¡Æ¤
  16. ¿·¤·¤¤Ëã¿ìÌô¥¢¥Í¥ì¥à®¤ÎºÆÄÃÀŤ˴ؤ¹¤ëÄ´ºº¤ª¤è¤ÓͽËÉÊýË¡¤Î¸¡Æ¤
  17. À¸³è½¬´·É¤Ȥ½¤Î¼£ÎÅÌô¤¬½ÑÃ椪¤è¤Ó½Ñ¸å¹çÊ»¾É¤ËÍ¿¤¨¤ë±Æ¶Á
  18. ¥Ð¥¤¥¿¥ë¥µ¥¤¥óÇÈ·Á¤òÍѤ¤¤¿½ÑÃ楢¥Ê¥Õ¥£¥é¥­¥·¡¼¿ÇÃÇ
  19. ·ì±Õ¶Å¸Çǽ¸¡ºº¤òÍѤ¤¤¿COVID-19½Å¾É²½Í½Â¬¤Ë´Ø¤¹¤ë¸¡Æ¤
  20. Ķû»þ´ÖºîÍÑ·¿Èóæʬ¶ËÀ­¶ÚÃдËÌô¤Î³«È¯¤òÌܻؤ·¤¿´ðÁÃŪ¸¡¾Ú
  21. ¿¼¤¤¶ÚÃд˰ݻý¤Î¤¿¤á¤Î¥í¥¯¥í¥Ë¥¦¥à»ý³ÅêÍ¿Î̤θ¡Æ¤
  22. Ê¢¹Ð¶À²¼Æ¬Äã°Ì¼ê½Ñ¤Ë¤è¤ë°öƬÄË¡¢ÓÎÀ¼¤Î¸¶°ø¤È°öƬpH¡¢¸ý¹ÐÆâºÙ¶Ý¿ô¤È¤Î´ØÏ¢¤Ë¤Ä¤¤¤Æ¤Î¸¡Æ¤
  23. ·Ð¶»ÊÉĶ²»ÇÈ¥¨¥³¡¼¤ò»ÈÍѤ·¤¿·ò¾ï¼Ô¤Ë¤ª¤±¤ëConcordÂΰ̡ÊÊ¢²é°Ì¡ÜƬ¹â°Ì¡Ë¤Î½Û´Ä·ì±ÕÎ̤ÎÊѲ½¤Ë¤Ä¤¤¤Æ¤Î¸¦µæ
  24. Ëã¿ìƳÆþ»þ¤Ë¹á¤êÉÕ¥Þ¥¹¥¯¤ò»ÈÍѤ·¡¢¾®»ù´µ¼Ô¤Î¥¹¥È¥ì¥¹·Ú¸º¤È¤Ê¤ë¤«
  25. ¾®»ùÎؾõ¹Ã¾õ´ÖËìÀü»É¤Î°ÂÁ´À­¸þ¾å¤Î¤¿¤á¤ÎÀü»É¥â¥Ç¥ë¤Î³«È¯¡§Ä¶²»ÇÈ¥¨¥³¡¼¤Ë¤è¤ëÁÞ´É»þ¤Îµ¤´É¤ÎÊѰ̤ˤĤ¤¤Æ¤Î¸¡Æ¤
  26. Usefulness of the supraglottic airway device for congenital laryngeal atresia
  27. ¥é¥Ã¥ÈŦ½ÐÞõή¿´Â¡¤Ë¤ª¤±¤ë¿´¶Ú¼ý½ÌÆ°Â֤ιâÀºÅÙ²òÀÏ
  28. ¾ÃËÉÄ£¥Ç¡¼¥¿¥Ù¡¼¥¹¤òÍѤ¤¤¿ÁÉÀ¸¸åͽ¸å¤Ë´Ø¤¹¤ëÄ´ºº
  29. ¿´ÇÙÁÉÀ¸¸åǾ¾É¤ÎÄÃÀźޤˤè¤ëǾÊݸîÀïά
  30. Æó»À²½ÃºÁǤòÍѤ¤¤¿ÀÔ¿ñµõ·ì¤ËÂФ¹¤ë¿·¤¿¤Ê¼£ÎÅÀïά
  31. ¥Þ¥¦¥¹·ì¾®Èĸº¾¯¥â¥Ç¥ë¤ÎºîÀ®
  32. ÁÉÀ¸¸åµ­²±¾ã³²¤ËÂФ¹¤ë°ì»À²½ÃâÁǤòÍѤ¤¤¿¿·µ¬¼£ÎÅË¡¤Î³«È¯
  33. ¥¯¥é¥Ã¥·¥å¾É¸õ·²¤Î¿·µ¬¼£ÎÅÀïά
  34. Ç®Ãæ¾É¤Î¿·µ¬¼£ÎÅÀïά
  35. ¿´Ää»ßÁÉÀ¸¸åǾ¾ã³²¤ËÂФ¹¤ë¿åÁǥʥΥХ֥ë¤Î¼£ÎŸú²Ì¤Î¸¡¾Ú
  36. ¥Þ¥¦¥¹¿´Ää»ßÁÉÀ¸¥â¥Ç¥ë¤Ë¤ª¤±¤ë°ì»À²½ÃâÁǥʥΥХ֥ë¿å¤Î¼£ÎŸú²Ì¤Î¸¡¾Ú
  37. ¿´ÇÙÁÉÀ¸¸å¤Î¹â¼¡Ç¾µ¡Ç½¾ã³²¤ËÂФ¹¤ë¥Ø¥×¥·¥¸¥ó»ºÀ¸Á˳²Ìô¤òÍѤ¤¤¿¿·µ¬¼£ÎÅË¡¤Î³«È¯
  38. µ¤´ÉÀÚ³«¸å¤Îµ¤´É·Â¾å¤ÎÊѲ½
  39. TEVAR¤ÈEVAR¤Î¼þ½Ñ´üMACE¤ÎȯÀ¸¤Ë´Ø¤¹¤ë¸¡Æ¤
  40. Ëã¿ìÌô¤Ë¤è¤ëPOA£æ¤Ø¤Î±Æ¶Á
  41. Brugada·¿¿´ÅÅ¿Þ¤ò»ý¤Ä´µ¼Ô¤Î¼þ½Ñ´ü¤Î¿´¼¼À­ÉÔÀ°Ì®¤ÎȯÀ¸¤Ë¤Ä¤¤¤Æ
  42. ϳÅͶ»´µ¼Ô¤Ë¤ª¤±¤ë¶»³Ô·ÁÀ®¤òÌÜŪ¤È¤·¤¿¥Ú¥¯¥¿¥¹¥Ð¡¼ÁÞÆþ¤Ë¤è¤ë¿´Â¡¤ÎÅŵ¤À¸Íý³ØŪÆÃÀ­¤Ø¤Î±Æ¶Á
  43. ÆóʬÀÔÄǹçʻǥ¿±¤ËÂФ·¤Æ¹ÅË쳰Ķ²»Çȸ¡ºº¤ò»Ü¹Ô¤·¤¿4¾ÉÎã
  44. µÞÀ­Âå¼ÕÀ­¥¢¥·¥É¡¼¥·¥¹¤ËÂФ¹¤ë½Åú»À¥Ê¥È¥ê¥¦¥à¤ÎÍ­¸úÀ­¸¡¾Ú¥é¥ó¥À¥à²½Èæ³Ó»î¸³
  45. ½¸Ãæ¼£Îż¼¤Ç¤Î¥±¥¢¤ËÂФ¹¤ë²È²¤ÎËþ­ÅÙ¤ò¬Äꤹ¤ë¼ÜÅÙ FS-ICU 24R-J¤ÎÂÅÅöÀ­¸¡¾Ú
  46. À©¸ÂŪ»ÀÁDz½ÌÜɸ¤ÈÈóÀ©¸ÂŪ»ÀÁDz½ÌÜɸ¤òÈæ³Ó¤¹¤ëÂ絬ÌÏ¥é¥ó¥À¥à²½¥ì¥¸¥¹¥È¥ê»î¸³
  47. ½¸Ãæ¼£ÎŤòÍפ·¤¿¿··¿¥³¥í¥Ê¥¦¥¤¥ë¥¹´¶À÷¾É´µ¼Ô¤Î¿ÇÎÅ¡¦¥±¥¢¤Ë´Ø¤¹¤ëõº÷Ū¸¦µæ
  48. ËÜË®¤Ë¤ª¤±¤ë COVID-19 ´¶À÷´µ¼Ô¼£ÎŤαֳØŪĴºº
  49. µÞÀ­Äã»ÀÁÇÀ­¸ÆµÛÉÔÁ´¤ËÂФ¹¤ëÈ󿯽±Åª¿Í¹©¸ÆµÛ¤ò¸úΨŪ¤Ë³èÍѤ¹¤ë¸ÆµÛ´ÉÍýÀïά¤Ë¤Ä¤¤¤Æ¤Î¸å¤í¸þ¤­¸¡Æ¤
  50. ½Å¾É´µ¼Ô¤Ë¤ª¤±¤ë»ý³Ū·ì±ÕÆ©ÀÏÎÅË¡»þ¤Î¥á¥·¥ë»À¥Ê¥Õ¥¡¥â¥¹¥¿¥Ã¥È¤Î»êŬÅêÍ¿Î̤Îõº÷
  51. ÆüËܽ¸Ãæ¼£ÎÅ°å³Ø²ñ¼çºÅ¤ÎICUÆþ¼¼´µ¼ÔÅÐÏ¿¥·¥¹¥Æ¥à»ö¶È¤Ø¤Î»²²è
  52. ½Å¾É´µ¼Ô¤Î»ý³Ū¿ÕÂåÂØÎÅË¡¤ÎÆ©ÀϱÕήÎ̤ΰ㤤¤Ë¤è¤ë»À±ö´ðÊ¿¹Õ¤Ø¤Î±Æ¶Á
  53. Æñ¼£À­áÖÄ˵ڤÓËýÀ­áÖÄˤËÂФ¹¤ë³ØºÝŪ¼£ÎŤÎ¿ÌÌŪɾ²Á
  54. ËýÀ­ÄˤËÂФ¹¤ëǧÃιÔÆ°ÎÅË¡¤Î̵ºî°Ù²½Èæ³Ó»î¸³¤Ë¤è¤ë¸ú²Ì¸¡¾Ú
  55. ¼§µ¤¶¦ÌIJèÁüË¡¤òÍѤ¤¤¿ËýÀ­áÖÄËǾ¥Ð¥¤¥ª¥Þ¡¼¥«¡¼¤Î³ÎΩ
  56. ¥ß¥¯¥í¥°¥ê¥¢²èÁü²½PET¤È¥Þ¥ë¥Á¥â¡¼¥À¥ëMRI¤Ë¤è¤ëÄˤߤμÀ´µÊ̥Х¤¥ª¥Þ¡¼¥«¡¼¤Î³ÎΩ
  57. ¿·¤·¤¤´¶³ÐÄêÎ̻´ïintercross-220¤ÎÂÅÅöÀ­¤Î¸¡Æ¤
  58. Preoperative Versus Postoperative Ultrasound-Guided Rectus Sheath Block for Acute Postoperative Pain Relief After Laparoscopy: A Retrospective Cohort Study
  59. ´µ¼Ô¾ðÊó¥·¥¹¥Æ¥à¤òÍѤ¤¤¿½¸Ãæ¼£ÎÅÉô¤Îµ¡Ç½É¾²Á¡ÊJIPAD»ö¶È¡Ë
  60. JIKEI¡¡Airway¡¡management¡¡for¡¡patient¡¡safety¡¡course¡ÊJAMP¡Ë¼õ¹ÖÁ°¸å¤Ç¤Î¥Ó¥Ç¥ª¹¢Æ¬¶À¤Ë¤è¤ëÁ޴ɵ»½Ñ¤Î¸þ¾åÄ´ºº
  61. Rapid¡¡Response¡¡System¡ÊRRS¡Ë¥Ç¡¼¥¿¥ì¥¸¥¹¥È¥ê¡¼¤Ë´Ø¤¹¤ë¾»ÜÀß¹çƱ¸¦µæ
  62. ±¡Æâ¿´Ää»ßÅÐÏ¿¤Ë´Ø¤¹¤ë¾»ÜÀ߶¦Æ±ÅÐÏ¿¸¦µæ
  63. ͽ´ü¤»¤Ì¿´Ää»ß´µ¼Ô¤ÎÇطʤòÄ´ºº¤·¡¢¤µ¤é¤Ê¤ëͽ´ü¤»¤Ì¿´Ää»ß¤òËɤ°¤¿¤á¤Î¸å¤í¸þ¤­´Ñ»¡¸¦µæ
  64. Preoperative endoleak type in patients of aneurysmal sac expansion after endovascular aneurysm repair and intraoperative blood loss in aneurysmorrhaphy: analysis of a case series of 18 patients
¢¥ ¤³¤Î¥Ú¡¼¥¸¤Î¥È¥Ã¥×¤Ø
¼ç¤Ê¶ÈÀÓ
  1. ´ØÇî»Ö, ¢ëµªÊ¸, »Ö²ì½ÓºÈ, »°±ºÎÑ°ì, ¶áÆ£°ìϺ, ÌÚ²¼¿¿±û, ÀçƬ²Âµ¯, ÁýÅÄÍ´Ìé, ½ÐÌîÃÒ»Ë, ÃÓÅĹÀÊ¿, üâÌî¸÷»Ê, úɸ¶Íº´õ, °á³ÞÍü³¨, ŷë»Ë¾», º´ÏÂÄç¼£, ÁÄÉã¹¾ ϺÈ, ¿¹ºê¹À.ÉؿͲÊÊ¢¹Ð¶À¼ê½Ñ¤Ë¤ª¤±¤ë¥ª¥é¥ó¥¶¥Ô¥ó¤Î½Ñ¸å°­¿´¡¦ÓÒÅÇͽËɸú²Ì¡¡Â¿»ÜÀ߶¦Æ±Ìµºî°Ù²½Èæ³ÓÂоȻ. Ëã¿ì 2022; 71(7): 756-65.
  2. Takahashi K, Kobayashi Y, Sato M, Nagae S, Kondo I, Funaki S, Sato T, Konishi A, Ito Y, Kamide T, Hoshina T, Kanuka H, Kobayashi M, Sakurai Y, Iwamoto M, Takahashi H, Samura O, Okamoto A. Clinical outcomes in pregnant women with coronavirus disease 2019 in a perinatal medical centre in Japan: a retrospective study of the first 1 year of the pandemic. Obstet Gynaecol. 2022; 42(7): 2684-92.
  3. Katori N, Yamakawa K, Yagi K, Kimura Y, Doi M, Uezono S. Characteristics and outcomes of unplanned intensive care unit admission after general anesthesia. BMC Anesthesiol 2022; 2022(1): 191.
  4. Nakanishi T, Oyama K, Tanaka H, Kobirumaki-Shimozawa F, Ishii S, Terui T, Ishiwata S, Fukuda N. Effects of omecamtiv mecarbil on the contractile properties of skinned porcine left atrial and ventricular muscles. Front Physiol 2022; Epub 2022 Aug 23.
  5. Yoshitani K, Ogata S, Kato S, Tsukinaga A, Takatani T, Kin N, Ezaka M, Shimizu J, Furuichi Y, Uezono S, Kida K, Seo K, Kakumoto S, Miyawaki H, Kawamata M, Tanaka S, Kakinohana M, Izumi S, Uchino H, Kakinuma T, Nishiwaki K, Hasegawa K, Matsumoto M, Ishida K, Yamashita A, Yamakage M, Yoshikawa Y, Morimoto Y, Saito H, Goto T, Masubuchi T, Kawaguchi M, Tsubaki K, Mizobuchi S, Obata N, Inagaki Y, Funaki K, Ishiguro Y, Sanui M, Taniguchi K, Nishimura K, Ohnishi Y. Effect of cerebrospinal fluid drainage pressure in descending and thoracoabdominal aortic repair: a prospective multicenter observational study. J Anesth 2023 Mar 21. [Online ahead of print.]
  6. Uchiyama K, Sato T, Sugimoto Y, Kawabe T, Kida K. Factors to consider when assessing the IDOCS study. The Lancet Haematology2022; 9(9): e638.
  7. Kida K, Sugimoto Y, Sato T. Use of a Bougie vs Endotracheal Tube With Stylet and Successful Intubation on the First Attempt Among Critically Ill Patients Undergoing Tracheal Intubation. JAMA 2022; 327(15): 1503.
  8. Kuwabara Y, Yamakawa K, Okui S, Miyazaki E, Uezono S. Association between surgical tracheostomy and chronic tracheal stenosis: A retrospective, single-center study. Front Med (Lausanne) 2022; 9: 1050784.
  9. Miyazaki Y, Hayashida K, Ikeda K, Marutani E, Magliocca A, Nagashima F, Ikeda T, Tainsh R, Buys E, Ichinose F. Inhaled nitric oxide improves post-cardiac arrest outcomes via guanylate cyclase-1 in bone marrow-derived cells. Nitric Oxide 2022; 125: 47-56.
  10. Takazawa T, Horiuchi T, Nagumo K, Sugiyama Y, Akune T, Amano Y, Fukuda M, Haraguchi T, Ishibashi C, Kanemaru E, Kato T, Katoh K, Kawano T, Kochiyama T, Kuri M, Kurita A, Matsuoka Y, Muramatsu T, Orihara M, Saito Y, Sato N, Shiraishi T, Suzuki K, Takahashi M, Takahashi T, Tanabe K, Tomioka A, Tomita Y, Tsuji T, Watanabe I, Yamada T, Yoshida N, Yamaguchi M, Saito S. The Japanese Epidemiologic Study for Perioperative Anaphylaxis, a prospective nationwide study: allergen exposure, epidemiology, and diagnosis of anaphylaxis during general. anaesthesia BJA 27 Mar 2023.
  11. Ezaka M, Marutani E, Miyazaki Y, Kanemaru E, Selig MK, Boerboom SL, Ostrom KF, Stemmer-Rachamimov A, Bloch DB, Brenner GJ, Ohshima E, Ichinose F. Oral Administration of Glutathione Trisulfide Increases Reactive Sulfur Levels in Dorsal Root Ganglion and Ameliorates Paclitaxel-Induced Peripheral Neuropathy in Mice. Antioxidants(Basel) 2022; 11(11): 2122.
  12. Ikeda T, Amorim E, Miyazaki Y, Kato R, Marutani E, Silverman MG, Malhotra R, Solt K, Ichinose F. Post-cardiac arrest Sedation Promotes Electroencephalographic Slow-wave Activity and Improves Survival in a Mouse Model of Cardiac Arrest. Anesthesiology 2022; 137(6): 716-32.
  13. Nagashima F, Miyazaki Y, Kanemaru E, Ezaka M, Hara H, Sugiura K, Boerboom SL, Ostrom KF, Jiang W, Bloch DB, Ichinose F, Marutani E. Sulfide:quinone oxidoreductase ameliorates neurodegeneration in a murine model of Parkinson's disease. Redox Biol 2023; 59: 102562.
  14. Young PJ, Arabi YM, Bagshaw SM, Bellomo R, Fujii T, Haniffa R, Hodgson CL, Vijayaraghavan BKT, Litton E, Mackle D, Nichol AD, Kasza J, for the Mega-ROX management committee, the Australian and New Zealand Intensive Care Society Clinical Trials Group, the Critical Care Asia and Africa Network, the Irish Critical Care-Clinical Trials Group, and the Alberta Health Services Critical Care Strategic Clinical Network. Protocol and statistical analysis plan for the mega randomised registry trial research program comparing conservative versus liberal oxygenation targets in adults receiving unplanned invasive mechanical ventilation in the ICU(Mega-ROX). Crit Care Resusc 2022; 24 (2): 137-49.
  15. Tsutsumi Y, Tsujimoto Y, Tajika A, Omae K, Fujii T, Onishi A, Kataoka Y, Katsura M, Noma H, Sahker E, Ostinelli EG, Furukawa TA. Proportion attributable to contextual effects in general medicine: a meta-epidemiological study based on Cochrane reviews. BMJ Evid Based Med 2022; bmjebm-2021-111861.
  16. Kameda S, Fujii T, Ikeda J, Kageyama A, Takagi T, Miyayama N, Endo A, Uezono S. Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study. BMC Nephrol. 2023; 24(1): 12.
  17. Kurata S, Miyayama N, Ogawa K, Watanabe K, Asano K, Fujii T. Thromboembolic events in hospitalised patients with COVID-19: ecological assessment with a scoping review. BMJ Open 2023 Jan 30; 13(1): e066218.
  18. Annane D, Pittock SJ, Kulkarni HS, Pickering BW, Khoshnevis MR, Siegel JL, Powell CA, Castro P, Fujii T, Dunn D, Smith K, Mitter S, Kazani S, Kulasekararaj A. Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial. Lancet Respir Med 2023; S2213-2600(23):00082-6.
¢¥ ¤³¤Î¥Ú¡¼¥¸¤Î¥È¥Ã¥×¤Ø
¼ç¤Ê¶¥ÁèŪ¸¦µæÈñ
  • ²Ê³Ø¸¦µæÈñ½õÀ®»ö¶È¡¦´ðÈ׸¦µæ(C)
    ·Ñ³¡§±¡Æâ±ó³Ö°åÎÅ¥·¥¹¥Æ¥à¤òÍøÍѤ·¤¿½Ñ¸åáÖÄË´ÉÍý¥µ¡¼¥Ó¥¹(eAPS)¤Î¹½ÃۤȤ½¤Îɾ²Á¡Ê¾å±à¾½°ì¡Ë

  • ²Ê³Ø¸¦µæÈñ½õÀ®»ö¶È¡¦´ðÈ׸¦µæ¡ÊC¡Ë
    ·Ñ³¡§ËýÀ­Äˤˤª¤±¤ëÃæ¿õÀ­´¶ºî¤È¤Ï²¿¤«¡¼¥Þ¥ë¥Á¥â¡¼¥À¥ëMRI¤Ë¤è¤ë²òÌÀ¡ÊÁÒÅÄÆóϺ¡Ë

  • ²Ê³Ø¸¦µæÈñ½õÀ®»ö¶È¡¦´ðÈ׸¦µæ¡ÊC¡Ë
    ·Ñ³¡§Ä¶Ã»»þ´ÖºîÍÑ·¿Èóæʬ¶ËÀ­¶ÚÃдËÌô¤Î³«È¯¤òÌܻؤ·¤¿´ðÁÃŪ¸¡¾Ú¡Ê¿Ü±Ê¹¨¡Ë

  • ²Ê³Ø¸¦µæÈñ½õÀ®»ö¶È¡¦´ðÈ׸¦µæ¡ÊC¡Ë
    ·Ñ³¡§¿´Ää»ßÁÉÀ¸¸åǾ¾ã³²¤ËÂФ¹¤ë¿åÁǥʥΥХ֥ë¤Î¼£ÎŸú²Ì¤Î¸¡¾Ú¡ÊÃÓÅĹÀÊ¿¡Ë

  • ²Ê³Ø¸¦µæÈñ½õÀ®»ö¶È¡¦´ðÈ׸¦µæ¡ÊC¡Ë
    ·Ñ³¡§¥é¥Ã¥ÈŦ½ÐÞõή¿´Â¡¤òÍѤ¤¤¿¿´¶Ú¼ý½ÌÆ°Â֤ΥʥΥì¥Ù¥ë²òÀÏ¡ÁËã¿ìÌô¤Ë¤è¤ë±Æ¶Á¤Î¸¡¾Ú¡Á¡Ê¾È°æµ®»Ò¡Ë

  • ²Ê³Ø¸¦µæÈñ½õÀ®»ö¶È¡¦´ðÈ׸¦µæ¡ÊC¡Ë
    ·Ñ³¡§Æó»À²½ÃºÁǤˤè¤ë¿·¤¿¤ÊÀÔ¿ñÊݸîÀïά¡ÊÌÚÅĹ¯ÂÀϺ¡Ë

  • ²Ê³Ø¸¦µæÈñ½õÀ®»ö¶È¡¦´ðÈ׸¦µæ¡ÊC¡Ë
    ·Ñ³¡§ÁÉÀ¸¸åµ­²±¾ã³²¤ËÂФ¹¤ë°ì»À²½ÃâÁǤòÍѤ¤¤¿¿·µ¬¼£ÎÅË¡¤Î³«È¯¡ÊÃ漼ӱѡË

  • ²Ê³Ø¸¦µæÈñ½õÀ®»ö¶È¡¦¼ã¼ê¸¦µæ¡¦·Ñ³
    µÞÀ­¿Õ¾ã³²¤ËÂФ¹¤ë»ý³·ì±ÕÆ©ÀϤιñºÝɸ½àÎ̤ÈÆüËÜɸ½àÎ̤θ¡¾Ú¡§¥é¥ó¥À¥à²½Èæ³Ó»î¸³¡ÊÆ£°æÃÒ»Ò¡Ë
¢¥ ¤³¤Î¥Ú¡¼¥¸¤Î¥È¥Ã¥×¤Ø
¹ÖºÂ¡Ê¸¦µæ¼¼¡ËÆȼ«¤Î¥Û¡¼¥à¥Ú¡¼¥¸URL
Åìµþ»ü·Ã²ñ°å²ÊÂç³Ø¡¡Ëã¿ì²Ê³Ø¶µ¼¼
http://www.jikeimasuika.jp/
¢¥ ¤³¤Î¥Ú¡¼¥¸¤Î¥È¥Ã¥×¤Ø